DOES GRAFT VERSUS HOST DISEASE INFLUENCE TEMPO OF IMMUNOLOGICAL RECOVERY AFTER ALLOGENEIC HUMAN MARROW TRANSPLANTATION - OBSERVATION ON 56 LONG-TERM SURVIVORS